Riskpilot← Back to searchSign inGet full accessMEDENS AB
ABActiveOrg 5569092694Malmmyravägen 6General medical practice activities · NACE 8621Est. 20120 employees
Revenue 2024
SEK 2,4M
+13% vs 2023
EBITDA margin
43.4%
+107% vs 2023
Equity ratio
59.2%
Financial strength
Net profit 2024
SEK 760K
-53% vs 2023
| Revenue | SEK 2,4M | +13% |
| EBITDA | SEK 1,1M | +107% |
| Net profit | SEK 760K | -53% |
| Total assets | SEK 11,4M | +4% |
| Equity | SEK 6,7M | +6% |
| Employees | 0 | — |
Legal name
MEDENS AB
Org number
5569092694
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 november 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsult inom allmän medicin samt därmed förenlig verksamhet. Bolaget skall även bedriva handel med aktier och fastigheter samt därmed förenlig verksamhet.
Address
Malmmyravägen 6
Email
armaxh@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 571 | 2 157 | 2 077 | 2 165 | 2 438 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 770 | 30 | 766 | 511 | 1 059 |
| Depreciation & amort. | −62 | −0 | −0 | −15 | −89 |
| EBIT | 1 708 | 30 | 766 | 496 | 970 |
| Net financials | 105 | 464 | −1 | 1 025 | 31 |
| Profit before tax | 2 063 | 494 | 1 164 | 1 912 | 971 |
| Tax | −334 | −438 | −373 | −290 | −211 |
| Net profit | 1 729 | 56 | 791 | 1 622 | 760 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 971 | 8 948 | 9 580 | 10 939 | 11 399 |
| Equity | 5 079 | 4 335 | 4 943 | 6 334 | 6 744 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 313 | 429 | 254 | 190 | 186 |
| Total debt | 313 | 429 | 254 | 190 | 186 |
EBITDA margin
43.4%
This company
15.8%
Market median
+175% vs market
20202024
Equity ratio
59.2%
This company
38.2%
Market median
+55% vs market
20202024
Return on equity
11.3%
This company
18.4%
Market median
+39% vs market
20202024
Net profit margin
31.2%
This company
8.1%
Market median
+285% vs market
20202024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20202024
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-05-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDENS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Atdhe Maxhuni | Deputy Board Member | 0 companies |
| Dua Maxhuni | Deputy Board Member | 0 companies |
| Arbër Maxhuni | Board of Directors | 0 companies |